Publications
Vyome’s research team actively contributes to the scientific community, publishing on immune signaling, antimicrobial resistance, and novel therapeutic mechanisms.
Checkerboard Analysis To Evaluate Synergistic Combinations of Existing Antifungal Drugs and Propylene Glycol Monocaprylate in Isolates From Recalcitrant Tinea Corporis and Cruris Patients Harboring Squalene Epoxidase Gene Mutation
Sardana K, Gupta A, Sadhasivam S, Gautam RK, Khurana A, Saini S, Gupta S, Ghosh S. Antimicrob Agents Chemother.
Read More
Mechanistic Insight Into the Antifungal Effects of a Fatty Acid Derivative Against Drug-Resistant Fungal Infections
Bhattacharyya A, Sinha M, Singh H, Patel RS, Ghosh S, Sardana K, Ghosh S, Sengupta S. Front Microbiol.
Read More
Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients With Clindamycin-Resistant Cutibacterium Acnes
Batra R, Sadhasivam S, Saini S, Gupta S, Bisen RKS, Sinha M, Ghosh S, Jain S. Drugs R D.
Read More
Newly Developed Anti-Dandruff Regimen, VB-3222, Delivers Enhanced Sensorial and Effective Therapeutic Benefits Against Moderate Adherent Dandruff
Sadhasivam S, Garkhal K, Singh H, Yadav V, Chawrai S, Ramnane M, Jain S, Sardana K, Ghosh S. Clin Cosmet Investig Dermatol.haryya A, Sadhasivam S, Sinha M, Gupta S, Saini S, Singh H, Khurana A, Sachdeva S, Sardana K, Ghosh S. Int J Dermatol.
Read More
A Rationally Designed Multifunctional Antibiotic for the Treatment of Drug-Resistant Acne
Ghosh S, Sinha M, Bhattacharyya A, Sadhasivam S, Megha J, Reddy S, Saini S, Singh H, Kumar D, Kaur SP, Mishra M, Usharani D, Ghosh S, Sengupta S. J Invest Dermatol.
Read More
Evaluation of Therapeutic Potential of VB-001, a Leave-On Formulation, for the Treatment of Moderate Adherent Dandruff
Bhattacharyya A, Jain N, Prasad S, Jain S, Yadav V, Ghosh S, Sengupta S. BMC Dermatol.
Read More
